Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

dvm360® is now accepting applications for the 2025 Hospital Design360 Competition. Share your innovative veterinary practice design and demonstrate how it enhances efficiency, patient care, and ...